Hemant Vishwakarma THESEOBACKLINK.COM seohelpdesk96@gmail.com
Welcome to THESEOBACKLINK.COM
Email Us - seohelpdesk96@gmail.com
directory-link.com | smartseoarticle.com | webdirectorylink.com | directory-web.com | smartseobacklink.com | seobackdirectory.com | smart-article.com

Article -> Article Details

Title Animal Health MarketTrends, Share, Growth Factors, Analysis, and Forecast 2025-2033
Category Fitness Health --> Health Articles
Meta Keywords Animal Health Market
Owner Imarc
Description

Market Overview

The global animal health market was valued at USD 38.99 Billion in 2024 and is projected to reach USD 51.33 Billion by 2033. It is expected to grow at a CAGR of 2.79% during the forecast period 2025-2033. The market is primarily driven by an increasing number of pet owners, technological advancements, and rising awareness of zoonotic diseases worldwide. North America dominantly holds a 44.9% market share in 2024, supported by growing veterinary care demand and stringent government regulations.

Study Assumption Years

  • Base Year: 2024
  • Historical Years: 2019-2024
  • Forecast Period: 2025-2033

Animal Health Market Key Takeaways

  • Current Market Size: USD 38.99 Billion in 2024
  • CAGR: 2.79%
  • Forecast Period: 2025-2033
  • North America holds the largest market share of 44.9% in 2024.
  • Growth drivers include rising pet adoption and increased awareness of zoonotic diseases.
  • Advances in veterinary medicine such as biologics, pharmaceuticals, and diagnostics are improving disease management.
  • Government regulations and initiatives promote animal welfare, biosecurity, and food safety.
  • The United States accounts for 86.5% of North America's animal health market share.

Sample Request Link: https://www.imarcgroup.com/animal-health-market/requestsample

Market Growth Factors

The rising outbreaks of zoonotic infections are significantly encouraging investments in vaccines, diagnostics, and antimicrobial therapies to control diseases. Governments worldwide are implementing stricter regulations and surveillance programs aimed at monitoring and preventing the transmission of zoonotic diseases. Public awareness campaigns focus on promoting responsible pet ownership and vaccination efforts to reduce disease risks in communities. Additionally, the livestock industry is adopting biosecurity measures to minimize outbreaks and ensure compliance with food safety standards.

Technological advancements are playing a crucial role in driving the animal health market. Advances in veterinary diagnostics enable early detection and rapid response to emerging zoonotic threats. Pharmaceutical companies are developing novel therapeutics and biologics to effectively combat zoonotic diseases in animals. Increased funding for veterinary research is fostering innovations in disease prevention and treatment solutions. The integration of digital technologies is enhancing disease monitoring, outbreak prediction, and real-time data sharing, facilitating improved management of health risks.

Growing pet humanization and specialty pet care are also key growth contributors. With pets increasingly regarded as family members, consumer behavior is shifting towards premium and specialized pet care products and services. For example, in the US, 35% of young adults have adopted or plan to adopt pets, increasing demand for advanced veterinary care and personalized treatments. Additionally, innovations such as activity tracking collars for pets have gained popularity, especially among millennials, signifying a move towards comprehensive pet health management.

Market Segmentation

Analysis by Animal Type:

  • Commercial: Includes livestock and poultry reared for milk, meat, and other commercial needs. Producers are investing in preventive healthcare for maintaining herd health and increasing productivity. Collaborations with veterinary professionals enhance animal health management.
  • Companion: Not provided in source.

Analysis by Product Type:

  • Pharmaceuticals: Dominates the market with 57.0% share in 2024. These products help in disease prevention, treatment, and chronic illness management for pets and farm animals. Research and development in this segment focus on innovative and species-specific medications.
  • Biologicals: Not provided in source.
  • Medicinal Feed Additives: Not provided in source.
  • Diagnostics: Not provided in source.

Regional Insights

North America is the dominant region with a 44.9% market share in 2024, driven by a large pet-owner population and a growing livestock industry demanding animal health solutions. The region benefits significantly from active pharmaceutical companies and research institutions fostering continuous innovation in veterinary products. Government regulations further promote animal welfare and biosecurity, bolstering market expansion. For instance, in April 2022, the FDA approved bovine somatotrophin to enhance milk production in dairy cows, highlighting regulatory support for market growth.

Recent Developments & News

  • January 2025: Ceva Animal Health acquired rights to produce and launch products using Touchlight's dbDNA technology, aimed at developing innovative DNA vaccines for animal health.
  • November 2024: MSD Animal Health (Merck & Co.) announced European Commission approval for BRAVECTO® TriUNO, a new chewable tablet for dogs targeting internal and external parasites.
  • October 2024: The Indian government initiated a USD 25 million G20 Pandemic Fund to enhance livestock health coverage in response to pandemics. The initiative will be executed jointly with the Asian Development Bank, World Bank, and FAO and is planned to be completed by August 2026.
  • February 2024: Merck Animal Health acquired Elanco Animal Health's aqua business outside the US and Canada for USD 1.3 billion, including medicines, vaccines, and supplements for aquatic species, and associated manufacturing and research facilities.

Key Players

  • Bayer
  • Elanco
  • Merck
  • Merial
  • Zoetis Inc.
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Neogen
  • Novartis
  • Thermo Fisher Scientific
  • Vetoquinol
  • Virbac

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

????Get Custom Market Research for Your Business????

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302